Quick Answer
TANDEM DIABETES CARE INC reported Operating Income Loss of -$187.26 million for the year ending 2025.
- TANDEM DIABETES CARE INC showed a decrease of -88.9% in Operating Income Loss from 2024 to 2025.
- This data is from TANDEM DIABETES CARE INC's annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), TANDEM DIABETES CARE INC's Operating Income Loss has declined by 466.6%.
- Historical annual values: Fiscal year 2025: -$187.26 million | Fiscal year 2024: -$99.13 million | Fiscal year 2023: -$233.23 million | Fiscal year 2022: -$92.85 million | Fiscal year 2021: $22.65 million | Fiscal year 2020: -$7.96 million | Fiscal year 2019: -$16.72 million | Fiscal year 2018: -$44.63 million | Fiscal year 2017: -$62.94 million | Fiscal year 2016: -$78.05 million | Fiscal year 2015: -$69.00 million | Fiscal year 2014: -$75.66 million | Fiscal year 2013: -$49.43 million | Fiscal year 2012: -$33.05 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: